News
ADTX
0.0027
-71.58%
-0.0068
Aditxt (ADTX) Stock Sinks 20% After-Hours: Here’s What’s Going On
Benzinga · 11h ago
Major Investor Makes Bold Moves in Aditxt Stock Shake-Up
TipRanks · 15h ago
HRT Financial LP disposes of 5,120,480 Aditxt shares worth $92,169
PUBT · 20h ago
Aditxt initial beneficial ownership filing shows HRT Financial LP holds 2.4 million shares
PUBT · 20h ago
9 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 20h ago
BUZZ-U.S. STOCKS ON THE MOVE-Broadcom, Micron, Qualcomm
Reuters · 23h ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
Nasdaq Orders Aditxt Stock Delisted After Compliance Failures
TipRanks · 1d ago
Nasdaq panel delists Aditxt, trading suspension set for June 25
PUBT · 1d ago
Aditxt Expands Secured Convertible Note Financing Capacity
TipRanks · 1d ago
ADiTx files initial beneficial ownership statement for Tai Wey Ann
PUBT · 1d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 1d ago
ADITXT - INCREASES SENIOR SECURED CONVERTIBLE NOTES TO $6.25 MLN - SEC FILING
Reuters · 1d ago
Aditxt amends note deal, raising senior secured convertible notes to USD 6.25 million
PUBT · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras
Reuters · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 2d ago
Why Tianci International Shares Are Trading Higher By Around 88%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Aditxt initial beneficial ownership filing shows Takeover Time 2026 LLC stake of 3,420,439 shares
PUBT · 2d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 2d ago
More
Webull provides a variety of real-time ADTX stock news. You can receive the latest news about Aditxt Inc through multiple platforms. This information may help you make smarter investment decisions.
About ADTX
Aditxt, Inc. is a social innovation platform accelerating promising health innovations. The Company operates four programs focused on autoimmunity, cancer and early disease detection, infectious diseases and women’s health. Its subsidiaries include Adimune, Inc. (Adimune), Pearsanta, Inc., Adivir, Inc. and Adifem, Inc. Adimune is focused on its immune modulation therapeutic programs. Adimune’s proprietary immune modulation product, Apoptotic DNA Immunotherapy (ADI), utilizes a novel approach that mimics the way its bodies naturally induce tolerance to our own tissues. Adivir, Inc. is focused on building a portfolio of antiviral and other antimicrobial solutions designed to target life-threatening viral infections and emerging pathogens. Pearsanta, Inc. is engaged in the development of molecular tests based on mitochondrial DNA to develop tests for early detection of cancer. It is also focused on addressing a critical challenge in cancer care: optimizing therapy selection.